Skip to main content

Table 1 Patient characteristics

From: Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations

Patient characteristics (%)
Age (years)
 Range 54–79
Gender
 Male 5 (33.3)
 Female 10 (76.7)
Smoking status
 Non-smoker 9 (60.0)
 Former Smoker 6 (40.0)
Stage
 IV 14 (93.4)
 rIVa 1 (6.6)
1st line 5 (33.3)
2nd line 7 (46.7)
3rd line 2 (13.4)
Subsequent therapy 1 (6.6)
  1. arIV recurrent stage IV